In addition, Pat thinks then beginner investors should cultivate two important qualities: a healthy sense of skepticism and patience.
[text_ad]
Investors should approach all investments with a healthy sense of skepticism. This can help keep you out of fraudulent stocks that masquerade as high-quality stocks. It will also keep you out of legally operated, but poorly managed, companies that promise more than they can possibly deliver.
If you are a new investor, you should also realize that losing patience can cause you to sell your best choices right before a big rise. All too often, investors buy a promising stock just as it enters a period of price stagnation. Even the best-performing stocks run into these unpredictable phases from time to time. They move mainly sideways in a wide range for months or years before their next big rise begins. (Stock brokers often refer to these stocks as “dead money.”)
If you lack patience, you run a big risk of selling your best choices in the midst of one of these phases, prior to the next big move upward. If you lose patience and sell, you are particularly likely to do so in the low end of the trading range, when stock prices have weakened and confidence in the stock has waned.
[text_ad]
Newmont is poised to take over as the world’s biggest gold producer....
The company acquired its main asset, the past-producing Bloom Lake iron-ore mine, in April 2016 for $10.5 million....
Many people begin an investing career with a single purchase—one stock, say, or a mutual fund. They may harbor a mistaken or exaggerated idea of the gains this investment will bring. They’ll follow up with more investments, and results will vary widely....
The fund first sold shares to the public at $10 a unit, and began trading on Toronto in April 2004....
Northland owns, or has a stake in, 1,754 megawatts of generating capacity, with an additional 584 megawatts under construction.
The company owns a 60% stake in Project Gemini, a 600-megawatt wind farm (Northland’s share is 360 megawatts) located off the coast of the Netherlands....
This will be our last Inner Circle Q&A for 2017. Our next Q&A will go out on Wednesday, January 3, 2018. Now is a good time to say Thanks! to the many long-time friends, associates and kindred spirits who make up the membership of this unique organization....
The company is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat patient populations suffering from serious diseases but with a need for more medical therapies and interventions....